Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension.

If you have ocular hypertension, the pressure inside your eye is above normal. Pressure builds because the eye's fluid, known as the aqueous humor, doesn't drain properly. Ocular hypertension ...

H-1337 is under clinical development by D. Western Therapeutics Institute and currently in Phase II for Open-Angle Glaucoma.

Our purpose is to update the comprehensive ophthalmologist about the results of the Ocular Hypertension Treatment Study and the current clinical management of ocular hypertension. In the Ocular ...

Purpose: To review the literature regarding ocular hypertension following intravitreal antivascular endothelial growth factor therapy, and to propose a novel mechanism for the development of ...

“Since 2007, we have been studying L. barbarum’s neuroprotective effects in a series of ocular hypertension mouse models, as well as in humans with degenerative eye disease,” says So.

and in its product candidate PAXTRAVA™ (travoprost intracameral implant or OTX-TIC), which is currently in a Phase 2 clinical ...

The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has ...

According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.